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FORMULASI DAN PENILAIAN EMULSI NANO BERASASKAN ESTER 
MINYAK SAWIT UNTUK PENYAMPAIAN KETOPROFEN SECARA 
TOPIKAL 
ABSTRAK 
 
Dalam kajian ini emulsi dengan nisbah surfaktan atau dengan campuran (Tween 80®, 
Tween 85®, dan Span 20®) yang berbagai disediakan dengan menggunakan ester 
minyak sawit (POE) sebagai fasa minyak. Ketelusan cahaya melalui campuran 
tersebut digunakan sebagai penanda visual menandakan emulsi nano telah terbentuk 
dan dipastikan dengan mengukur saiz titisan melalui spektroskopi penyerakan laser 
(Nanophox). Kawasan gel pada diagram fasa segitiga yang dihasilkan diguna sebagai 
satu criteria bagi menentukan kesesuaian nilai HLB agen emulsi nano untuk POE 
dan untuk memilih pelbagai formula yang berpotensi. Telah diketahui bahawa 
kawasan gel yang terbesar terhasil daripada HLB 15, 13.72 dan 12. Daripada 
diagram 3 fasa tersebut, 3 poin yang sama iaitu A, B dan C telah dipilih dan 
campuran POE dan surfaktant seperti terkandung dalam mereka diguna untuk 
menentukan kelarutan ketoprofen.  Kelarutan ketoprofen dalam POE dengan 
surfaktan HLB 15 pada poin C telah ditentukan sebagai yang tertinggi (134.33 
mg/ml).  Berdasarkan kepada kelarutan dan data fasa segitiga, surfaktan HLB 15 
dengan POE telah dinilai sebagai campuran minyak-surfaktan yang paling baik untuk 
menyediakan emulsi nano mengandungi ketoprofen.  Kajian terhadap pembebasan 
dan pemindahan drug melalui membrane selulosa metil asetat dan kulit tikus dalam 
‘Franz diffusion cells’ telah dilaksanakan. Ketoprofen yang terbebas dan 
dipindahkan dibandingkan dengan produk yang berada di pasaran. Profil pelepasan 
dan pemindahan in vitro tersebut menunjukkan peratusan ketoprofen yang 
xiv 
 
mencukupi terbebas melalui membrane selulosa tersebut.  Pelepasan dan pemindahan 
ketoprofen dari emulsi nano tanpa peningkat penyerapan lebih rendah dengan 
signifikan berbanding dari produk di pasaran. Peningkatan kepekatan limonen 
sebagai ajen peningkat penyerapan didapati meningkatkan penembusan ketoprofen 
dari emulsi nano yang diformulasikan.  Keputusan yang diperolehi menunjukkan 
bahawa emulsi nano dengan kadar 3% limonen menghasilkan ketelapan ketoprofen  
yang serupa melalui kulit tikus bila dibandingkan dengan formulasi yang berada di 
pasaran dan dipilih sebagai formulasi optimum. Ujian anti-inflamatori dan analgesik 
dari formulasi optimum yang dipilih dilakukan terhadap tikus. Keputusan ujian 
tersebut menunjukkan bahawa emulsi nano mengandungi ketoprofen dan 3% 
limonen mempunyai kesan anti-inflamatori dan analgesik lebih tinggi dan signifikan 
berbanding control. Akan tetapi tiada perbezaan yang signifikan berbanding produk 
di pasaran. Dari hasil kajian ini dapat dirumuskan bahawa emulsi nano POE 
mengandungi ketoprofen yang telah diformulasikan mempunyai potensi yang besar 
sebagai penghantar topikal ketoprofen. 
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FORMULATION AND EVALUATION OF PALM OIL ESTERS BASED 
NANO-EMULSION FOR TOPICAL DELIVERY OF KETOPROFEN 
ABSTRACT 
In this study emulsions with varying ratios of surfactant or its mixtures (Tween 80®, 
Tween 85® and Span 20®) were prepared using POE as the oil phase. The 
transparency of the mixtures was used as visual indications that nano-emulsions were 
formed and were reconfirmed by measuring the droplets size using laser scattering 
spectroscopy (Nanophox).  The gel area of the triangle phase diagrams produced was 
used as one of criteria to determine the suitable HLB value of the nano-emulsion’s 
emulsifier for POE and for selection of several promising formulae.  It was noted that 
largest gel area produced by HLB 15, 13.72 and 12. From these three phase diagrams 
three common points namely A, B and C were selected and mixtures of POE and 
surfactant constituted in them were used to study the solubility of ketoprofen.  The 
determined solubility of ketoprofen in POE with surfactant HLB 15 point C was the 
highest (134.33 mg/ml).  Based on the solubility and triangle phase diagram data, 
surfactant HLB 15 with POE was judged as the best surfactant- oil mixture for 
preparing ketoprofen loaded nano-emulsion.  The study on drug release and transfer 
through the cellulose membrane and rat skin in Franz diffusion cells were carried 
out.  The in vitro release profile shows sufficient percentage of ketoprofen was 
released through the membrane. The transfer of ketoprofen through rat skin from 
nano-emulsion containing no enhancer was found to be significantly lower than from 
the product available in market. Utilization of limonene as a penetration enhancer 
increased the permeation of ketoprofen from the formulated nano-emulsion with 
increasing concentrations of limonene. The results obtained showed that nano-
emulsion with 3% limonene produced similar and comparable skin permeation of 
xvi 
 
ketoprofen with marketed formulation thus selected as the optimum formula.  The 
anti-inflammatory and analgesic effects of the selected optimum formulation were 
performed on rats. The results indicated that ketoprofen nano-emulsion had 
significant anti-inflammatory and analgesic effects than control. However, there is no 
significant different between the effects of POE nano-emulsion formulation and 
marketed formulation.  From these results it can be concluded that the POE nano-
emulsion of ketoprofen formulated has great potential for topical delivery of 
ketoprofen. 
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CHAPTER 1 
INTRODUCTION 
 
1.1   EMULSIONS 
Emulsion is a dosage form that has been traditionally used for a considerable period 
in pharmacy.  Emulsions can be design for oral, parental and topical use. Emulsion is 
defined as heterogeneous system comprising at least two immiscible liquid phases 
where one liquid dispersed as globules (dispersed phase) in the other liquid 
(continuous phase) (Otto et al., 2009, Sherman, 1983). Colloidal drug delivery 
systems such as micro-emulsion and nano-emulsion are increasingly focused by 
formulators in recent years.  It is an important formulation type for poorly water 
soluble drug in pharmaceutical dosage form (Shakeel et al., 2008, Shafiq et al., 
2007) because, optimization of the solubility of poorly water-soluble drugs in 
pharmaceutical dosage forms presents a challenge, due to restrictions of solvents 
suitable for drug delivery.  Formulation can also plays a key role in influencing the 
absorption and bioavailability of poorly water soluble drug (Moshfeghi and Peyman, 
2005, Service, 2004). Depending on the nature of the dispersed and continuous 
phase, different types of emulsions can be distinguished as following: 
 
1.1.1 OIL IN WATER (O/W) EMULSIONS 
Emulsions with an oleaginous internal phase and aqueous external phase are referred 
to as oil-in-water (o/w) emulsions. These types of emulsions are important in the 
preparation of poorly water soluble actives /drugs for cosmetic and medicinal 
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formulations. O/w emulsions are formulated for parental and topical administration 
but also for oral and ocular drug deliveries (Tamilvanan and Benita, 2004). These are 
the type of emulsions most commonly used and popular especially in topical delivery 
because they have initial cooling effects due to evaporation of water, thus giving a 
good feeling to the skin (Miller et al., 1999). Moreover o/w emulsions do not make 
the skin look very shiny and are less likely to block the pores. These properties will 
increase their acceptance by the users (Swarbrick and Boylan, 1996).  
 
1.1.2 WATER IN OIL (W/O) EMULSIONS 
Emulsions having an aqueous internal phase and an oleaginous external phase are 
termed as water-in-oil (w/o) emulsions. These are less popular emulsions when 
compared to o/w emulsion.  This type of emulsion forms a thin film on the skin 
surface and this will control dehydration (Mitsui et al., 1997). 
 
1.1.3 W/O/W OR O/W/O EMULSIONS 
Multiple or w/o/w and o/w/o emulsions are defined as emulsions with both types 
(o/w and w/o) exist simultaneously, where a dispersed phase is contained within 
another dispersed phase and they have at least two types of surfactants (Florence and 
Whitehill, 1982).  The entrapment of active ingredient in the inner dispersed phase 
can lead to the delayed release and extended duration of action. 
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1.1.4 NANO-EMULSIONS 
Nano-emulsions are a class of emulsions with very small and uniform droplets size, 
typically in the range of 20 – 500 nm (Porras et al., 2008, Usón et al., 2004).  Due to 
their small droplets size, most of nano-emulsions are transparent or translucent, 
resembling micro-emulsions (Usón et al., 2004). In contrast to micro-emulsions, 
nano-emulsions are not thermodynamically stable (Tadros et al., 2004), but they may 
have high kinetic stability because their small droplets size makes them stable 
against sedimentation and creaming (Tadros et al., 2004).  All of these characteristic 
properties have led to an increase use of nano-emulsions in many different 
applications related to chemical, pharmaceutical and cosmetic.  
 
In the literature, this type of liquid/liquid dispersions are also referred to as 
submicron emulsions (Sznitowska et al., 2001) mini-emulsions and ultrafine 
emulsions (Nakajima et al., 1990).  The term nano-emulsion is increasingly used 
because it gives a clear idea of the nano-scale range of the droplets size, avoiding 
misinterpretations with other kinds of dispersions such as micro-emulsions (Solans et 
al., 2005). 
 
The nano-emulsion delivery system is an effective formulation option, especially for 
poorly water soluble actives or drugs (Shakeel et al ., 2007).  The major challenge of 
poorly water soluble substances is their efficacy can be severely limited by instability 
or poor solubility in the vehicle.  Nano-emulsion system offers enhance drug 
solubility and bioavailability of lipophilic and poorly water soluble drugs (Shafiq et 
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al., 2007). The nano-sized droplets leading to an enormous increase in total 
interfacial areas associated with nano-emulsion would influence the transport 
properties of the drug (Shakeel et al., 2008, Shafiq-un-Nabi et al., 2007, Lawrence 
and Rees, 2000,). 
 
Nano-emulsions can be prepared by using a high-energy dispersion method (Leong 
et al., 2009, Mao et al.,2009) or by spontaneous emulsification method or titration 
method (Shafiq-un-Nabi et al., 2007, Shakeel et al., 2007, Shafiq et al., 2007, 
Sadurní et al., 2005).  Preparation of nano-emulsions by spontaneous emulsification 
method offers much more advantages than using high-energy method.  High energy 
method using mechanical energy such as high-shear energy or high pressure energy 
could be too costly and formed high amount of ‘foams’ during processing, which 
will led to difficulty in handling (SolÃ¨ et al., 2006).  Preparation of nano-emulsion 
by spontaneous process is simple and can be achieved with mild agitation (Shafiq-
un-Nabi et al., 2007).  In this process nano-emulsions can be prepared by adding 
water to an oil and surfactant mixture and agitate simply by a magnetic stirrer at a 
constant temperature (Shakeel et al., 2007). 
 
The transparency of nano-emulsions help us to assess them for any microbial growth 
and allow inspection for the presence of undissolved drug. The transparency is also 
useful in topical preparation, because a clear system is aesthetically more pleasing. In 
a nutshell nano-emulsions are potential drug carriers for oral, topical and parental 
administrations. They offer several advantages such as spontaneous formation, ease 
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of manufacturing and scale up, kinetic stability, transparency, improved drug 
solubilization and enhanced bioavailability. 
 
Table 1.1 shows a summary of some work carried out on nano-emulsions which were 
reported in literature during last two decades.  It is noted that in recent years i.e. 
2009, 2008 and 2007, the published papers has increased enormously on nano-
emulsion than in ‘90s (see Table 1.1).  Most of these papers reported they used the 
non-ionic surfactants such as Tween 80® to formulate nano-emulsion.  It is also 
important to note that, most of nano-emulsions formulated for topical delivery were 
oil-in-water type formulations. 
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Table 1.1: Summary of some literatures on nano-emulsion published in the past 
years. 
Oil Emulsifier Type Drug / active Route References 
Palm oil 
esters Span 20® o/w 
lipophilic 
drugs Transdermal 
Abdul Rahman et 
al., 2009 
Capmul 
MCM Tween 80® o/w Risperidone Transmucos 
Kumar et al., 
2009b  
Oleic acid Tween 20® o/w Amlodipine Transdermal 
Kumar et al., 
2009a 
Virgin 
coconut oil 
Emulium 
kappa o/w 
Kojic 
dipalmitate Topical Al-Edresi, 2009 
Soybean oil 
Tween 80®,  
Span 80® o/w Cisplatin  Intravesical 
Hwang et al., 
2009 
Lauroglycol 
90 Transcutol o/w Caffeine Transdermal 
Shakeel and 
Ramadan, 2009 
FCaproyl Tween 80®   Nitrindipine Intranasal 
Jain and 
Patravale, 2009 
Oleic acid Tween 20®   Domperidone Transdermal 
Akhter et al., 
2008 
Benzylc Solutol o/w Ketoprofen Transdermal Kim et al., 2008 
Palm oil 
esters 
Tween 20® , 
Span 80® o/w 
lipophilic 
drugs Transdermal Basri et al., 2008 
Soybean oil Tween 80®   Camphor, Transdermal Mou et al., 2008,  
      Menthol     
Soybean oil Tween 80® o/w Aspirin Oral 
Subramanian et 
al., 2008 
Oleic acid Tween 80® o/w Carvedilol Transdermal Dixit et al., 2008 
Sefsol Tween 80® o/w Celecoxib Transdermal 
Baboota et al., 
2007 
Sefsol Tween 80® o/w Ramipril Oral Shafiq et al., 2007 
Castor oil Tween 80® o/w Aceclofenac Transdermal 
Shakeel et al., 
2007 
Camphor 
EL Miglyol o/w Lidocaine not mention 
Sadurní et al., 
2005 
not mention not mention o/w 
Stroidal and 
non-steroidal 
drugs Transdermal 
Friedman et al., 
1995 
not mention not mention o/w Diazepam Transdermal 
Friedman et al., 
1994 
 
 
 
 
 
7 
 
1.2 TRANSDERMAL DELIVERY 
 
Transdermal drug delivery has many advantages over most of other conventional 
routes of administration which include; avoidance of the hepatic first-pass 
metabolism, enhanced therapeutic efficacy, better patient medication compliance and 
reduced systemic side effects (Park et al., 2000).  Therefore, there has been an 
increased interest in recent years in pharmaceuticals and cosmeceuticals fields to use 
topical formulations to deliver drugs or actives through the skin.  
 
1.2.1 THE HUMAN SKIN 
 
The skin is the largest organ of the body, accounting for more than 10% of body 
mass and the one that enables the body to interact most intimately with its 
environment. It is one of the most extensive, readily accessible organs and is the 
heaviest single organ of the body which combines with the mucosal linings of the 
respiratory, digestive and uro-genital tracts to form a capsule which separates the 
internal body structures from the external environment (Barry, 1983). 
 
A diagrammatical cross-section through human skin is presented in Figure 1.1. The 
skin consists of three layers namely the epidermis, dermis and subcutaneous tissue. 
There are also several associated appendiges such as hair follicles, sweat ducts, 
apocrine glands and nails (Buck, 2004; Wiiliams, 2003;Barry, 1983). 
 
The epidermis is divided into four anatomical layers namely stratum basale, stratum 
spinosum, stratum granulosum and stratum corneum (Wiiliams, 2003, Barry, 1983) 
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as shown in Figure 1.1. The stratum corneum is the heterogeneous outermost layer of 
the epidermis and is approximately 10-20µm thick. The cells of the stratum corneum, 
keratinocytes originate in the viable epidermis and undergo many morphological 
changes. The keratinocytes are metabolically active and capable of mitotic division 
(Buck, 2004, Wiiliams, 2003). 
 
 
 
Figure 1.1: A diagrammatical cross-section through human skin (Skin cross section 
diagram (2010),World Wide Web: GoogleTM ) 
 
 
The dermis (or corneum) at 3 to 5 mm thick, is much thicker than the overlying 
epidermis which it supports and thus makes up the of the skin (Barry, 1983). The 
dermis, which provides the elasticity of the skin, contains immune cells and has the 
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vascular network that supplies the epidermis with nutrients that can carry absorbed 
substances in to the body (Buck, 2004). Blood vessels, nerves and lymphatic vessels 
cross this matrix and skin appendages (endocrine sweat glands, apocrine glands and 
pilosebaceous unit). 
 
1.2.2 ABSORPTION THROUGH THE SKIN 
 
For transdermal delivery to be effective, drugs have to enter into the viable skin in 
sufficient quantities to produce a therapeutic effect. The possible pathways for 
transdermal drug delivery are intercellular routes and shunt routes as have been 
reported by Williams (2003). Drugs are transported through appendages such as hair 
follicles, transcellular transport through the corneocytes and intercellular transport 
via the extracellular matrix (Barry, 1983).  Although the routes of drugs penetration 
through the stratum corneum include follicular regions, sweat ducts and intact 
stratum corneum, they are influenced by skin condition, skin age, blood supply, 
species variation, hydration and concentration of the drug being administered. 
Furthermore, the characteristics of the applied agents also influence the penetration 
(Buck, 2004). 
 
1.2.3 NANO-EMULSIONS FOR TOPICAL DELIVERY 
 
Nano-emulsions as a topical carrier, offer many significant advantages such as good 
permeation ability and high drug-loading capacity (Tadros et al., 2004).  Several 
NSAID’s were successfully incorporated into nano-emulsion system (Table 1.1.).  
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Nano-emulsions are reported to be suitable for efficient delivery of active ingredients 
through the skin because the large surface area of the emulsion system allows rapid 
penetration of actives (Tadros et al., 2004).  Due to their small droplets size, nano-
emulsions can penetrate through the ‘rough’ skin surface and this enhances the 
penetration of actives or drugs.  The transparent nature of the nano-emulsion system, 
their fluidity (at reasonable oil concentration) as well as the absence of any 
thickeners may give them a pleasant aesthetic character and skin feel preferred by 
patients and consumers (Tadros et al., 2004). 
 
Several drugs have been incorporated into nano-emulsion system for transdermal 
delivery (Akhter et al., 2008, Shakeel et al., 2008, Shakeel et al., 2007, Schwarz et 
al., 1995, Friedman et al., 1995, Friedman et al., 1994, Subramanian et al., 2008). 
These researchers have concluded that nano-emulsion formulation may enhance the 
permeation through skin over the conventional formulation. 
 
Even though nano-emulsions show several advantages for topical delivery; some 
attempts are reported in literature to enhance the topical uptake of the drug from 
nano-emulsion, for example, positive submicron emulsions with permeation 
enhancement effect were studied (Youenang Piemi et al., 1999).  There is a finding 
(Mou et al., 2008) that nano-emulsion system with terpenes as enhancers (5% 
camphor, 5% menthol) shows good stability and powerful permeation ability for the 
topical delivery of a lipophilic drug.  
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The success of a transdermal drug delivery system depends on the ability of the drug 
to penetrate the skin in sufficient quantities to maintain the therapeutic level. 
Absorption through the skin is limited by a poor penetration of drugs across the 
stratum corneum (Park et al., 2000) therefore it is very important to overcome the 
skin barrier properties or stratum corneum.  Many strategies have been studied in 
order to overcome the skin barrier or stratum corneum and to enhance the 
permeability of drugs through the skin.  A popular approach is the use of penetration 
enhancers, which enhance the permeability of the stratum corneum (Barry, 2001, 
Southwell and Barry, 1984).  Penetration enhancers interact with the lipids of the 
outermost layer of the skin which lead to better penetration of co administered drugs 
(Bialik et al., 1993) and increased the rate of drug penetration (Guy and Hadgraft, 
1987). 
 
1.2.4  USE OF TERPENES IN TOPICAL DELIVERY 
Terpenes like menthol, cineole and limonene were used extensively in transdermal 
delivery system for many years to enhance the penetration of lipophilic drugs (Jain et 
al., 2002, Takayama et al., 1991). Terpenes, constituents of volatile oils exhibit 
excellent permeation-enhancing effects to facilitate transdermal drug delivery (Vaddi 
et al., 2002) and have been shown to enhance the permeation of both lipophilic 
drugs, such as testosterone  and hydrophilic drugs, such as propranolol (Vaddi et al., 
2002). 
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Terpenes are a very safe and effective class of penetration enhancers, obtained from 
natural sources.  The FDA classifies them as generally regarded as safe (GRAS) 
(Vaddi et al., 2002).  They cause no skin toxicity or if any, only mild irritation 
(Krishnaiah et al., 2003). Even though terpenes are considered to be skin irritants; 
they did not cause lasting erythema (Okabe et al., 1990).  
 
In an earlier report (Rhee et al., 2001) a transdermal preparation was developed to 
deliver ketoprofen with permeation enhancers namely; limonene, cineole, menthol 
and camphor. Out of this four terpenes used, only limonene resulted in a powerful 
enhancing activity. It increased the permeation ability of ketoprofen by 3 fold over 
the control (Rhee et al., 2001) and found to be a good penetration enhancer for 
ketoprofen by many researchers (Okabe et al., 1992, Okabe et al., 1990).  Based on 
these reports, limonene is chosen as a penetration enhancer to be used in this study to 
enhance the permeation of a model drug (ketoprofen) through rat skin. 
  
1.3  CHOICE OF KETOPROFEN AS A MODEL DRUG 
Several model drugs have been used to study nano-emulsions as illustrated in Table 
1.1. In this study, the nano-emulsion to be formulated will be used to entrap and 
deliver poorly water soluble drug topically and to improve its penetration through the 
skin to exert the expected effects.  Ketoprofen is poorly water soluble and is suitable 
candidate to be incorporated into nano-emulsion formulation, thus ketoprofen is 
chosen as model drug. 
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1.3.1  PHYSICO-CHEMICAL PROPERTIES 
 
   
Figure 1.2: Structural formula of ketoprofen 
Ketoprofen is, 3-Benzoyl-a-methylbenzeneacetic acid (Goosen et al., 1998). Its 
chemical formula is C16H14O3 and belongs to the aryl propionic acid class.  
Ketoprofen is a white or almost white, crystalline and odorless powder with a sharp 
bitter taste (Martindale, 2002).  The physico chemical properties of ketoprofen are 
listed in Table 1.2. 
Table 1.2: The physico-chemical properties of ketoprofen (Goosen et al., 1998) 
Physico-chemical properties Ketoprofen 
Chemical formula C16H14O3 
Molecular mass 254.29 
Log p 0.97 
pKa 4.45 
Solubility constraint 175.38 
Melting point 94.50C 
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1.3.2  PHARMACOLOGY, PHARMACODYNAMICS AND USES 
 
Ketoprofen is a potent non-steroidal anti-inflammatory drug (NSAID). It is used 
widely for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis 
and acute gouty arthritis (Patrono and Rocca, 2009, Brooks, 1998, Kantor, 1986).  It has 
anti-inflammatory, analgesic and antipyretic pharmacological properties. It has been 
frequently used to treat mild to moderate pain (Kantor, 1986). Like most NSAIDs, 
ketoprofen is advantageous because it lacks addictive potential and does not result in 
sedation or respiratory depression.  
 
Ketoprofen inhibits the cyclooxygenase responsible for the biosynthesis of 
prostaglandins (Patrono and Rocca, 2009, Vane and Botting, 1996).  Ketoprofen is 
rapidly absorbed after oral administration and maximal concentration in plasma is 
achieved within 1 to 2 hrs. Food reduces the rate but not the extent of absorption. 
The drug is extensively bound to plasma proteins (99%), and it has a half life in 
plasma about 2 hrs.  Ketoprofen is conjugated with glucuronic acid in the liver, and 
the conjugate is excreted in the urine (Hardman et al., 2001). Adverse and side effect 
of ketoprofen includes; gastro-intestinal erosions such as gastric, duodenal and 
intestinal (Patrono and Rocca, 2009, Hardman et al., 2001). 
 
1.3.2.1  ANTI-INFLAMMATORY EFFECTS 
In several animal models (rats, mice, rabbits, guinea pigs and pigeons) ketoprofen 
displayed potent activity against acute inflammation (increased vascular 
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permeability, edema and erythema), sub acute inflammation and chronic 
inflammation (Hardman et al., 2001, Kantor, 1986). Its anti-inflammatory activity is 
20 times more potent than ibuprofen and 160 times potent than aspirin (Hardman et 
al., 2001, Kantor, 1986). 
 
1.3.2.2  ANALGESIC AND ANTIPYRETIC EFECTS 
 Ketoprofen was shown to be a potent, peripherally acting analgesic. It was also 
shown to be equivalent to indomethacin, slightly more potent than naproxen and 30 
times more potent than aspirin in pain management (Hardman et al., 2001, Brooks, 
1998 , Kantor, 1986). Ketoprofen is currently marketed throughout the world in a 
variety of forms: capsules, tablets, injectables solutions, suppositories and gels. 
Available formulations are tabulated in Table 1.3. 
 
Table 1.3: Ketoprofen formulations available in the market. 
Rout of administration Dosage form Strength  
Oral Tablets 50 mg 
Enteric coated  100 mg 
Capsules 50 mg 
75 mg 
100 mg 
 Extended(controlled) 
release 
100 mg 
200mg 
 
Parental Intramuscular 100 mg / 2ml 
Rectal Suppository 100 mg 
Topical Gel 2.5 g / 100 g 
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1.3.3  KETOPROFEN AS TOPICAL DOSAGE FORM 
There are several reports in literature about ketoprofen (Cordero et al., 2001, Cordero 
et al., 1997), which accomplishes that ketoprofen is suitable for topical dosage form, 
because it exhibits many physio-chemical properties for percutaneous permeation.  
Ketoprofen is an excellent candidate for transdermal delivery among various 
NSAIDs (Cordero et al., 1997).  Its plasma levels were maintained relatively 
consistent for about 24 hrs after transdermal application (Chi and Jun, 1989).  
Ketoprofen has a relatively short half life and has the potential to be delivered 
topically (Jamali and Brocks, 1990).  It’s low molecular weight, low melting point 
and high lipophilicity may contribute to good skin permeability (Cordero et al., 
1997). 
Various transdermal dosage forms containing ketoprofen have been reported, 
including patches (Yim et al., 1996), gels (Chi and Jun, 1991) and ointments (GuÌˆrol 
et al., 1996),  but none of these dosage form used palm oil esters (a new 
enzymatically synthesized palm oil ) as one of their main ingredient. 
 
1.3.4  ASSAY OF KETOPROFEN 
 
It is important to quantify the drug in order to analyze how much ketoprofen is 
released or permeated through the skin (artificial membrane or biological 
membrane).  Several methods have been reported for the analysis of ketoprofen and 
many numerous chromatographic methods to quantify ketoprofen in different medias 
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have been published; serum (Alvi et al., 1998), plasma (Chi and Jun, 1989) and also 
in in vitro samples for pharmaceuticals (Dejalan et al., 2000). 
 
1.4 CHOICE OF OTHER MATERIALS TO PRODUCE NANO-
EMULSIONS 
1) Palm Oil Esters (POE) 
2) Non-ionic surfactants 
3) Limonene 
1.4.1 PALM OIL ESTERS (POE) 
Traditionally palm oil is used, mainly as cooking oil, shortening, butter substitutes, 
creamer, margarine, and in soap and detergent industries. With the advent of the oleo 
chemical industries based on palm and palm kernel oil feed stocks during the past 
decade; diversification of palm oil usage into nontraditional areas is gaining 
importance. It is beginning to find other uses in the nonfood areas, notably in 
cosmetics and personal care products. Research bodies in Malaysia such as Malaysia 
Palm Oil Board (MPOB) and Universiti Putra Malaysia (UPM) are actively 
modifying palm oil into better constituents having improved properties and new 
applications.  
 
Palm oil consists of triglycerides, a combination of glycerol and different fatty acids. 
The fruit of the palm tree Elaesis guineenis is the source of two distinctively 
different oil types.  The outer pulp contains palm oil and the nut in the fruit contains 
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kernels that are the source of palm kernel oil. Palm oil and palm kernel oil differ 
considerably in their characteristics and properties even though they are derived from 
the same plant (Keng et al., 2009).  Palm oil is rich in C16 and C18 fatty acids, while 
palm kernel oil is rich in C12 fatty acids.  These oils / fats can be further fractionated 
into solid and liquid fractions to yield stearins and olein, respectively. Alcoholysis of 
triglycerides from palm oil and palm kernel oil to produce wax esters (the new 
derivatives of palm oil and palm kernel) through enzymatic reaction by lipase is a 
relatively simple process and moreover, the starting materials are cheap (Keng et al., 
2008, Basri et al., 2007, Gunawan et al., 2005). 
 
The synthesis of palm oil esters (POE) was first reported by Gunawan et al., in 2004.  
In their work, they synthesized the esters using palm oil and long chain alcohols 
catalyzed by lipase enzyme. The work on the modification of palm oil in to palm oil 
esters (POE) has grown due to the possibility of obtaining a wide variety of high 
quality natural products under mild reaction conditions utilizing selective enzyme as 
environment friendly biocatalysts (Keng et al., 2009, Keng et al., 2008, Basri et al., 
2007).  
 
Palm Oil       +    Alcohol                  →               Palm Oil Esters 
                                                        Lipase 
                                                                                                    (Gunawan et al., 2004) 
 
The POE has gained interest among researchers because it can produce nano-
emulsion (Abdul Rahman et al., 2009, Basri et al., 2008) and can be use as a 
substitute for jojoba oil which is rich in oil esters but very costly.  Basri et al., (2008) 
in their study have shown that POE and nonionic surfactants can be used to produce 
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nano-emulsions and have suggested that POE are suitable for use as a new ingredient 
for pharmaceuticals and cosmeceuticals especially for topical delivery (Keng et al., 
2009, Basri et al., 2008) because of their small droplets size, high droplets volume 
and exceptional stability. 
 
A molecular dynamic study on nano-emulsions produced by POE and non-ionic 
surfactants was studied by Abdurrahman et al., (2009).  From their simulation study 
on the ability of palm based nano-emulsion to self-assemble and the size of the 
micelle resulted, they suggested that palm-based nano-emulsion has great potential to 
be used in transdermal delivery due to its low energy micelle formation pathway. 
Thus, POE are a new ingredient for pharmaceutical industry (Abdul Rahman et al., 
2009, Keng et al., 2009, Basri et al., 2008, , Keng et al., 2008,). The oil has no 
irritation on human skin, it increases the skin hydration due to its moisturizing 
properties and it shows high thermal stability (Keng et al., 2009), it could be used in 
cosmetic or medicinal formulations to deliver poorly water-soluble lipophilic actives 
or drugs (Abdul Rahman et al., 2009, Basri et al., 2008) and is very cheap when 
compared to jojoba oil. 
 
1.4.2 SURFACTANTS 
Amphiphilic molecules or surfactants or emulsifiers are characterized by the 
presence of both polar and nonpolar regions of the same molecule. This dual nature 
is responsible for the surface activity of these substances leading to accumulation at 
hydrophobic interfaces and formation of aggregates (Lawrence and Rees, 2000). 
Surfactants constitute the most important components of the emulsions. Generally, 
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these are water soluble surface-active agents comprised of a hydrophobic portion, 
usually a long alkyl chain, attached to hydrophilic functional groups.  Surfactant 
molecules will arrange themselves at the oil-water interface, reducing the interfacial 
free energy and tension hence increasing the thermodynamic stability of the emulsion 
formed (Khair, 2005). Emulsifying agents can be divided into three groups; synthetic 
agents, naturally occurring materials and finely divided solids. The synthetics groups 
are divided into anionic, cationic, non-ionic and amphoteric (having both anionic and 
cationic groups on the hydrophilic portion of the same molecule) agents. 
 
According to the reports from Abdulrahman et al., (2009) and Basri et al., (2008), 
the nano-emulsions could be prepared by mixing POE, water and nonionic 
surfactants without need of co-surfactants. Abdulrahman et al., (2009) used only 
Span 20® while Basri et al., (2008) used Span 20® and Tween 60® in their 
formulations.  Both of these studies attracted us to choose non-ionic surfactants in 
our study, to formulate POE nano-emulsions without the aid of co-surfactant. 
 
There are several reports that conclude, non-ionic surfactants could be able to form 
nano-emulsion without the need for a co-surfactant (Lawrence and Rees, 2000). This 
is helpful because it reduce the complexicity of phase behavior and eliminates the 
requirements for inclusion of medium chain alcohols / co-surfactants (Lawrence and 
Rees, 2000). Non-ionic surfactants such as Tween 80®, Tween 85® and Span 20® are 
selected as the emulsifier in this study due to their lack of their toxicity (Florence and 
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Rogers, 1971).  Moreover these non-ionic surfactants are less susceptible to acidic or 
alkaline hydrolysis as well as to decomposition by micro-organisms.  
 
Non-ionic surfactants have the ability to produce surfactant mixtures having wide 
range of Hydrophile-lipophile balance (HLB) values. HLB concept was first 
introduced by Griffin in 1949 (Pasquali et al., 2009) and developed in the 1950s. 
This concept has a mean of characterizing the surfactant (Pasquali et al., 2009).  HLB 
system provides the formulators with relevant information regarding emulsion 
formulation (Ishii and Nii, 2005).  By HLB method, each agent is assigned to HLB 
value or number indicating the substance’s polarity. The usual range is between 1 
and 20.  Materials that are highly polar or hydrophilic have been assigned to higher 
numbers than materials that are less polar or lipophilic.  
 
W/o emulsions can be obtained by using a surfactant with a low HLB (3-6), while 
o/w emulsions stabilization requires a higher HLB (8-18).  Algebraic manipulation is 
necessary when a blend of surfactants, with known HLBs, is used for a particular 
emulsification (Pasquali et al., 2009).  Emulsifiers such as blend of Tween 20® and 
Span 20® having high HLB value will form an o/w emulsion.  On the other hand 
Span 60® alone having a HLB of 4.7, tends to form a w/o emulsion. The type of 
emulsion produced is a function of the relative solubility of surfactant (Martin, 
1993).  Thus surfactants with high HLB are preferentially soluble in water and 
resulted in the formation of o/w emulsions while surfactants of low HLB are less 
soluble in water and tend to produce w/o emulsions 
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1.4.3 LIMONENE 
Limonene is a hydrocarbon lipophilic terpene, obtained from the lemon peel of 
Citrus limon.  It is a chiral molecule and as is common with such molecules, 
biological sources produce one specific enentiomer : D-limonene, ((+) – limonene). 
Racemic limonene is known as dipentene. (http://www.en.wikipedia.org/wiki/Limonene). 
Limonene was shown to enhance the percutaneous penetration of ketoprofen in 
several reports (Rhee et al., 2001, Okabe et al., 1992, Okabe et al., 1990) and chosen 
as a suitable candidate to be used in this study as a penetration enhancer of 
ketoprofen through biological membrane. 
 
1.5 SUMMARY AND PROBLEM STATEMENT 
Nano-emulsions offer several advantages as drug delivery systems and according to 
the studies by many researchers in this field; nano-emulsions have been formulated 
as parental, transdermal and oral delivery systems as well as topical preparations. 
Nano-emulsions offer the advantages of having a large surface area, ability to 
solubilize lipophilic drugs and relatively good stability and may improve the 
bioavailability of drug. 
 
Ketoprofen is a non-steroidal anti-inflammatory, analgesic and antipyretic drug used 
for the treatment of rheumatoid osteoarthritis, ankylosing spondylitis and gout. It is 
more potent than the other non-steroidal anti-inflammatory drugs (NSAIDs) with 
respect to some effects such as anti-inflammatory and analgesic activities. 
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Although ketoprofen administered orally is rapidly absorbed, metabolized and 
excreted, it causes some gastrointestinal complaints such as nausea, dyspepsia and 
some renal side effects like other NSAIDs.  Therefore, there is a great interest in 
developing topical dosage form of these NSAIDs to avoid the oral side effects and 
provide relatively consistent drug concentrations at the application site for prolonged 
period.  POE is new oil, which is cheap but rich in esters and is a suitable candidate 
for use as a substitute of jojoba oil, which is very expensive. 
 
1.6 SCOPE AND AIMS OF THE STUDY 
The main aim of this study is: 
To formulate o/w nano-emulsions containing non-ionic surfactants as emulsifier and 
palm oil esters (POE) as internal phase and water as the continuous phase, and 
ketoprofen as the model drug for transdermal delivery. To achieve this, the study was 
planned with following objectives. 
• To construct ternary phase diagrams with POE and various non-ionic 
surfactants (different HLB) and water, this will be used to select several 
promising formulae. 
• To determine the solubility of ketoprofen in POE alone and POE combination 
with non-ionic surfactants. 
• To determine the droplets size and transmission electron microscopic 
properties of nano-emulsion prepared. 
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• To develop a simple high performance chromatographic (HPLC) method for 
quantification of ketoprofen in samples collected from Franz diffusion cells 
after being transferred through methyl acetate cellulose membrane and through 
rat skin. 
• To study the transfer of ketoprofen through methyl cellulose membrane and 
rat skin (in-vitro-test) and to compare with marketed product. 
• To study the effect of penetration enhancer (limonene) on optimized 
formulation and to compare the release with the marketed formulation. 
• To conduct the pharmaco-dynamic studies; anti-inflammatory studies by 
carrageenan induced paw edema test and analgesic studies by hyperalgesia pain 
threshold test. 
• To study and evaluate visually for any irritation caused by the formulation.   
 
 
 
 
 
 
 
 
 
